Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II

Lisa M. Oppegard, Andrei V. Ougolkov, Doris N. Luchini, Renee A. Schoon, John R. Goodell, Harneet Kaur, Daniel D. Billadeau, David M. Ferguson, Hiroshi Hiasa*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II'. Together they form a unique fingerprint.

Medicine & Life Sciences